Bajpai, D., Mehdizadeh, S., Uchiyama, A., Inoue, Y., Sawaya, A., Overmiller, A., . . . Morasso, M. I. (2021). Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway. Oncogene.
Citação norma ChicagoBajpai, Deepti, et al. "Loss of DLX3 Tumor Suppressive Function Promotes Progression of SCC Through EGFR-ERBB2 Pathway." Oncogene 2021.
MLA CitationBajpai, Deepti, et al. "Loss of DLX3 Tumor Suppressive Function Promotes Progression of SCC Through EGFR-ERBB2 Pathway." Oncogene 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.